Newton Biocapital
Finance · Belgium · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Tervurenlaan 273, Bruxelles Woluwe-Saint...Website
www.newtonbiocapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Newton Biocapital
Newton Biocapital specializes in life sciences investments, focusing on maturing innovation and supporting the growth of portfolio companies to create value for patients, society, and investors. The company leverages strong ties to the life sciences ecosystems in Europe and Japan, unlocking unique opportunities for optimal exits. Their strategy emphasizes supporting projects that address chronic health conditions, utilizing their scientific expertise and network to identify promising investment opportunities. Newton Biocapital actively participates in the governance of its portfolio companies, aiding in the selection of preclinical and clinical programs across various technologies and disease areas.Explore more
Newton Biocapital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Newton Biocapital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Newton Biocapital recently announced quarterly report
Product Launch: Get notified when Newton Biocapital launches new products
Congratulate Masked Content for being promoted to Masked Content at Newton Biocapital
Check out if Newton Biocapital is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Newton Biocapital has recently received funding, and reach out quickly before it becomes old news!
Click to see if Newton Biocapital had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Newton Biocapital has new funding data
Newton Biocapital, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Newton Biocapital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Newton Biocapital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Newton Biocapital.
Newton Biocapital Tech Stack
A closer look at the technologies used by Newton Biocapital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Newton Biocapital News & Media
Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy
BRUSSELS, BELGIUM, June 22, 2021 /EINPresswire.com/ -- Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe and Japan focused on chronic diseases, has announced its investment in a new Walloon start-up of the ULB: NeuVasQ …Newton Biocapital invests in Flemish start-up DeuterOncology
BRUSSELS, BELGIUM, February 24, 2021 /EINPresswire.com/ -- Newton Biocapital I (“Newton Biocapital”), a life sciences investment fund active in Europe and Japan focused on chronic diseases, has announced investment in DeuterOncology. Newton Biocapital’s …
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Newton Biocapital
Sign Up For FreeTo access detailed company insights
Newton Biocapital specializes in life sciences investments, focusing on maturing innovation and supporting the growth of portfolio companies to create value for patients, society, and investors. The company leverages strong ties to the life sciences ecosystems in Europe and Japan, unlocking unique opportunities for optimal exits. Their strategy emp... Read More
